Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Aberrant Simultaneous ERK and CDK2 Kinase Activity Discloses Leukemia

Gernot Stuhler, Matthias Krusch, Stefan Stevanovic, Stefan Gattenlöhner, Helmut R. Salih, MD

Blood (2010) 116 (21): 2487.

https://doi.org/10.1182/blood.V116.21.2487.2487

Published: 2010

Journal Articles

CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells

Tina Baessler, Jean Enno Charton, Benjamin Joachim Schmiedel, Frank Grünebach, Matthias Krusch, Alexander Wacker, Hans-Georg Rammensee, Helmut Rainer Salih

Blood (2010) 115 (15): 3058–3069.

https://doi.org/10.1182/blood-2009-06-227934

Published: 2010

Journal Articles

Consequences of 4-1BB-4-1BB Ligand Interaction for NK Cell Anti-Tumor Immunity: Opposite Effects of Seemingly Analogue Molecules in Mice and Men.

Tina Baessler, Jean E Charton, Corina Buechele, Benjamin J Schmiedel, Frank Gruenebach, Matthias Krusch, MD, Alexander Wacker, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2009) 114 (22): 279.

https://doi.org/10.1182/blood.V114.22.279.279

Published: 2009

Journal Articles

The Role of the PI3K-AKT-mTOR Pathway in NK Cell Anti-Tumor Reactivity.

Matthias Krusch, MD, Julia Salih, Ingrid Kumbier, Carolin Fenner, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2009) 114 (22): 3690.

https://doi.org/10.1182/blood.V114.22.3690.3690

Published: 2009

Journal Articles

The FLT3-Inhibitors Midostaurin, Sunitinib, Sorafenib, and TKI258 Differentially Affect NK Cell-Mediated Immunesurveillance of Acute Myeloid Leukemia.

Julia Salih, Lothar Kanz, MD, Helmut R Salih, MD, Matthias Krusch, MD

Blood (2009) 114 (22): 3785.

https://doi.org/10.1182/blood.V114.22.3785.3785

Published: 2009

Journal Articles

NK Cell Anti-Tumor Reactivity Is Impaired by Platelet-Derived TGF-B through NKG2D Downregulation

Hans-Georg Kopp, Theresa Placke, Benjamin J Schmiedel, Lothar Kanz, MD, Matthias Krusch, Helmut R Salih, MD

Blood (2008) 112 (11): 2859.

https://doi.org/10.1182/blood.V112.11.2859.2859

Published: 2008

Journal Articles

Differential Effects of the BCR-ABL-Inhibitors Imatinib, Nilotinib and Dasatinib on NK Cell Reactivity against Chronic Myeloid Leukemia (CML)

Matthias Krusch, MD, Julia Salih, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2008) 112 (11): 3200.

https://doi.org/10.1182/blood.V112.11.3200.3200

Published: 2008

Journal Articles

The Role of CD137 and Its Ligand in Chronic Lymphocytic Leukemia (CLL)

Tina Baessler, Corina Buechele, Matthias Krusch, Benjamin J Schmiedel, Lothar Kanz, Helmut R Salih

Blood (2008) 112 (11): 3130.

https://doi.org/10.1182/blood.V112.11.3130.3130

Published: 2008

Journal Articles

The Role of Activation-Induced C-Type Lectin (AICL) in NK Cell Reactivity against Acute Leukemia

Tina Baessler, Sabrina Kuttfruff, Matthias Krusch, Lothar Kanz, Alexander Steinle, Helmut R Salih

Blood (2008) 112 (11): 2517.

https://doi.org/10.1182/blood.V112.11.2517.2517

Published: 2008

Journal Articles

5-Azacytosine (Azacytidine) and 2′-Deoxy-5-Azacytidine (Decitabine) Mediate Opposite Effects on NK Cell Anti-Tumor Reactivity

Benjamin J Schmiedel, Viktor Arélin, Matthias Krusch, Lothar Kanz, Helmut R Salih

Blood (2008) 112 (11): 2626.

https://doi.org/10.1182/blood.V112.11.2626.2626

Published: 2008

Journal Articles

NK Cell Anti-Tumor Immune Responses Are Impaired by Sorafenib but Not by Sunitinib

Matthias Krusch, MD, Manuela Schlicke, Julia Salih, Tina Baessler, Lothar Kanz, MD, Helmut Salih, MD

Blood (2008) 112 (11): 2632.

https://doi.org/10.1182/blood.V112.11.2632.2632

Published: 2008

Journal Articles

Functional Characterization of Signaling Events Underlying Immunostimulatory and Immunosuppressive Activity of Macrophages.

Mercedes Kloss, Lothar Kanz, MD, Helmut R Salih, MD, Matthias Krusch, MD

Blood (2008) 112 (11): 1273.

https://doi.org/10.1182/blood.V112.11.1273.1273

Published: 2008

Journal Articles

Neutralization of tumor-derived soluble Glucocorticoid-Induced TNFR-Related Protein ligand increases NK cell anti-tumor reactivity

Katrin M. Baltz, Matthias Krusch, Tina Baessler, Benjamin J. Schmiedel, Anita Bringmann, Peter Brossart, Helmut R. Salih

Blood (2008) 112 (9): 3735–3743.

https://doi.org/10.1182/blood-2008-03-143016

Published: 2008

Includes: Supplemental data

Journal Articles

Toll-Like Receptor-Induced Expression of the NKG2D Ligand MICA on Monocytes Modulates Their Interaction with NK Cells.

Mercedes Kloss, Patrice Decker, PhD, Matthias Krusch, MD, Katrin M. Baltz, Tina Baessler, Lothar Kanz, MD, Alexander Steinle, PhD, Helmut R. Salih, MD

Blood (2007) 110 (11): 2415.

https://doi.org/10.1182/blood.V110.11.2415.2415

Published: 2007

Journal Articles

Role of Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand in the Interaction of Acute Myeloid Leukemia with NK Cells.

Matthias Krusch, MD, Katrin M. Baltz, Tina Baessler, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2007) 110 (11): 18.

https://doi.org/10.1182/blood.V110.11.18.18

Published: 2007

Journal Articles

Role of CD137/4-1BB and Its Ligand in the NK Cell Mediated Immune Surveillance of Acute Myeloid Leukemia.

Tina Baessler, Matthias Krusch, MD, Katrin M. Baltz, Benjamin J. Schmiedel, Helga M. Schmetzer, PhD, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2007) 110 (11): 880.

https://doi.org/10.1182/blood.V110.11.880.880

Published: 2007

Journal Articles

Direct and Natural Killer Cell-Mediated Anti-Tumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma.

Matthias Krusch, MD, Sorin Armeanu, PhD, Katrin M. Baltz, Ulrich M. Lauer, MD, Alexander Steinle, PhD, Lothar Kanz, MD, Michael Bitzer, MD, Helmut R. Salih, MD

Blood (2007) 110 (11): 4181.

https://doi.org/10.1182/blood.V110.11.4181.4181

Published: 2007

Journal Articles

Neutralization of Tumor-Derived Soluble Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand Present in Cancer Patient Sera Increases Anti-Tumor Reactivity of NK Cells.

Katrin M. Baltz, Matthias Krusch, MD, Tina Baessler, Anita Bringmann, Lothar Kanz, MD, Peter Brossart, MD, Helmut R. Salih, MD

Blood (2007) 110 (11): 314.

https://doi.org/10.1182/blood.V110.11.314.314

Published: 2007

Journal Articles

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Pearlie K. Epling-Burnette, Fanqi Bai, Jeffrey S. Painter, Dana E. Rollison, Helmut R. Salih, Matthias Krusch, JianXiang Zou, Edna Ku, Bin Zhong, David Boulware, Lynn Moscinski, Sheng Wei, Julie Y. Djeu, Alan F. List

Blood (2007) 109 (11): 4816–4824.

https://doi.org/10.1182/blood-2006-07-035519

Published: 2007

Includes: Supplemental data

Journal Articles

Expression of Glucocorticoid-Induced TNF Receptor Ligand on Acute Myeloid Leukemia Cells Mediates the Release of Immunosuppressive Cytokines and Impairs NK Cell-Mediated Immune Surveillance.

Matthias Krusch, MD, Katrin M. Baltz, Tina Baessler, Mercedes Kloss, Ingrid Kumbier, Andrea Peterfi, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2006) 108 (11): 1941.

https://doi.org/10.1182/blood.V108.11.1941.1941

Published: 2006

NARROW

Aberrant Simultaneous ERK and CDK2 Kinase Activity Discloses Leukemia

CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells

Consequences of 4-1BB-4-1BB Ligand Interaction for NK Cell Anti-Tumor Immunity: Opposite Effects of Seemingly Analogue Molecules in Mice and Men.

The Role of the PI3K-AKT-mTOR Pathway in NK Cell Anti-Tumor Reactivity.

The FLT3-Inhibitors Midostaurin, Sunitinib, Sorafenib, and TKI258 Differentially Affect NK Cell-Mediated Immunesurveillance of Acute Myeloid Leukemia.

NK Cell Anti-Tumor Reactivity Is Impaired by Platelet-Derived TGF-B through NKG2D Downregulation

Differential Effects of the BCR-ABL-Inhibitors Imatinib, Nilotinib and Dasatinib on NK Cell Reactivity against Chronic Myeloid Leukemia (CML)

The Role of CD137 and Its Ligand in Chronic Lymphocytic Leukemia (CLL)

The Role of Activation-Induced C-Type Lectin (AICL) in NK Cell Reactivity against Acute Leukemia

5-Azacytosine (Azacytidine) and 2′-Deoxy-5-Azacytidine (Decitabine) Mediate Opposite Effects on NK Cell Anti-Tumor Reactivity

NK Cell Anti-Tumor Immune Responses Are Impaired by Sorafenib but Not by Sunitinib

Functional Characterization of Signaling Events Underlying Immunostimulatory and Immunosuppressive Activity of Macrophages.

Neutralization of tumor-derived soluble Glucocorticoid-Induced TNFR-Related Protein ligand increases NK cell anti-tumor reactivity

Toll-Like Receptor-Induced Expression of the NKG2D Ligand MICA on Monocytes Modulates Their Interaction with NK Cells.

Role of Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand in the Interaction of Acute Myeloid Leukemia with NK Cells.

Role of CD137/4-1BB and Its Ligand in the NK Cell Mediated Immune Surveillance of Acute Myeloid Leukemia.

Direct and Natural Killer Cell-Mediated Anti-Tumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma.

Neutralization of Tumor-Derived Soluble Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand Present in Cancer Patient Sera Increases Anti-Tumor Reactivity of NK Cells.

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Expression of Glucocorticoid-Induced TNF Receptor Ligand on Acute Myeloid Leukemia Cells Mediates the Release of Immunosuppressive Cytokines and Impairs NK Cell-Mediated Immune Surveillance.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only